AAPL344.06-4.85 (-1.39%) ▼|ABBV293.97+3.18 (+1.09%) ▲|ABT106.22+1.65 (+1.57%) ▲|ACN258.79+11.57 (+4.68%) ▲|ADBE250.53+2.41 (+0.97%) ▲|AMAT389.01-32.66 (-7.74%) ▼|AMD503.68-62.74 (-11.08%) ▼|AMGN466.34+5.61 (+1.22%) ▲|AMT187.89+2.01 (+1.08%) ▲|AMZN240.14-3.65 (-1.50%) ▼|AVGO325.85-19.15 (-5.55%) ▼|AXP319.13-4.59 (-1.42%) ▼|BA171.56-1.09 (-0.63%) ▼|BAC50.03-1.12 (-2.18%) ▼|BKNG148.13-2.30 (-1.53%) ▼|BLK1,147.34-28.90 (-2.46%) ▼|BMY62.47+1.08 (+1.76%) ▲|BNY147.13-2.24 (-1.50%) ▼|BRK-B543.36+1.40 (+0.26%) ▲|C121.16-4.60 (-3.66%) ▼|CAT618.86-28.53 (-4.41%) ▼|CL95.90+2.74 (+2.94%) ▲|CMCSA23.09+0.82 (+3.68%) ▲|COF202.74-6.00 (-2.87%) ▼|COP153.47+3.44 (+2.29%) ▲|COST1,017.00+22.39 (+2.25%) ▲|CRM228.71-2.19 (-0.95%) ▼|CSCO103.70-4.89 (-4.50%) ▼|CVS90.27-0.06 (-0.07%) ▼|CVX235.43+3.97 (+1.71%) ▲|DE675.70+15.70 (+2.38%) ▲|DHR232.30-4.68 (-1.97%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK127.42+1.52 (+1.21%) ▲|EMR164.94-5.80 (-3.40%) ▼|FDX313.28+5.46 (+1.77%) ▲|GD372.61+1.79 (+0.48%) ▲|GE301.83-11.22 (-3.58%) ▼|GEV857.75-30.10 (-3.39%) ▼|GILD170.68+5.07 (+3.06%) ▲|GM87.40+1.68 (+1.96%) ▲|GOOG278.22-4.10 (-1.45%) ▼|GOOGL279.84-3.98 (-1.40%) ▼|GS894.45-33.28 (-3.59%) ▼|HD329.20+0.22 (+0.07%) ▲|HON218.33-3.81 (-1.72%) ▼|IBM257.81-0.47 (-0.18%) ▼|INTC65.76-26.31 (-28.58%) ▼|INTU341.09+9.90 (+2.99%) ▲|ISRG432.01-16.75 (-3.73%) ▼|JNJ273.20-2.00 (-0.73%) ▼|JPM337.04-6.54 (-1.90%) ▼|KO94.08+1.26 (+1.36%) ▲|LIN514.24+11.09 (+2.20%) ▲|LLY1,417.54+43.84 (+3.19%) ▲|LMT636.95-6.64 (-1.03%) ▼|LOW209.07+1.79 (+0.86%) ▲|LRCX239.11-15.28 (-6.01%) ▼|MA638.01+2.31 (+0.36%) ▲|MCD258.12+0.74 (+0.29%) ▲|MDLZ64.94+2.41 (+3.85%) ▲|MDT96.54-0.57 (-0.59%) ▼|META614.99-9.53 (-1.53%) ▼|MMM174.34-3.02 (-1.70%) ▼|MO78.03+1.28 (+1.67%) ▲|MRK149.52+3.19 (+2.18%) ▲|MS184.30-4.55 (-2.41%) ▼|MSFT521.91-8.23 (-1.55%) ▼|MU884.74-49.53 (-5.30%) ▼|NEE83.65+1.51 (+1.84%) ▲|NFLX61.82-0.23 (-0.37%) ▼|NKE38.59+0.17 (+0.43%) ▲|NOW104.94-4.73 (-4.31%) ▼|NVDA203.24-10.43 (-4.88%) ▼|ORCL130.67-8.89 (-6.37%) ▼|PEP137.34+3.55 (+2.65%) ▲|PFE30.52+0.57 (+1.90%) ▲|PG161.57+0.98 (+0.61%) ▲|PLTR184.11-12.31 (-6.27%) ▼|PM208.79+0.29 (+0.14%) ▲|QCOM164.68-20.73 (-11.18%) ▼|RTX199.80+0.40 (+0.20%) ▲|SBUX104.74-0.77 (-0.73%) ▼|SCHW87.70-1.77 (-1.98%) ▼|SO94.17+1.18 (+1.27%) ▲|SPG217.80+2.08 (+0.96%) ▲|T21.43+0.51 (+2.44%) ▲|TMO696.97-12.21 (-1.72%) ▼|TMUS156.44+9.15 (+6.21%) ▲|TSLA399.81-3.49 (-0.87%) ▼|TXN300.84-10.58 (-3.40%) ▼|UBER65.25-0.49 (-0.75%) ▼|UNH406.97-3.94 (-0.96%) ▼|UNP304.00+2.07 (+0.69%) ▲|UPS108.25+0.92 (+0.86%) ▲|USB59.45-1.19 (-1.96%) ▼|V413.59+3.05 (+0.74%) ▲|VZ44.73+1.07 (+2.45%) ▲|WFC83.40-1.41 (-1.66%) ▼|WMT123.51+2.26 (+1.86%) ▲|XOM187.25+3.96 (+2.16%) ▲|AAPL344.06-4.85 (-1.39%) ▼|ABBV293.97+3.18 (+1.09%) ▲|ABT106.22+1.65 (+1.57%) ▲|ACN258.79+11.57 (+4.68%) ▲|ADBE250.53+2.41 (+0.97%) ▲|AMAT389.01-32.66 (-7.74%) ▼|AMD503.68-62.74 (-11.08%) ▼|AMGN466.34+5.61 (+1.22%) ▲|AMT187.89+2.01 (+1.08%) ▲|AMZN240.14-3.65 (-1.50%) ▼|AVGO325.85-19.15 (-5.55%) ▼|AXP319.13-4.59 (-1.42%) ▼|BA171.56-1.09 (-0.63%) ▼|BAC50.03-1.12 (-2.18%) ▼|BKNG148.13-2.30 (-1.53%) ▼|BLK1,147.34-28.90 (-2.46%) ▼|BMY62.47+1.08 (+1.76%) ▲|BNY147.13-2.24 (-1.50%) ▼|BRK-B543.36+1.40 (+0.26%) ▲|C121.16-4.60 (-3.66%) ▼|CAT618.86-28.53 (-4.41%) ▼|CL95.90+2.74 (+2.94%) ▲|CMCSA23.09+0.82 (+3.68%) ▲|COF202.74-6.00 (-2.87%) ▼|COP153.47+3.44 (+2.29%) ▲|COST1,017.00+22.39 (+2.25%) ▲|CRM228.71-2.19 (-0.95%) ▼|CSCO103.70-4.89 (-4.50%) ▼|CVS90.27-0.06 (-0.07%) ▼|CVX235.43+3.97 (+1.71%) ▲|DE675.70+15.70 (+2.38%) ▲|DHR232.30-4.68 (-1.97%) ▼|DIS110.96+0.05 (+0.05%) ▲|DUK127.42+1.52 (+1.21%) ▲|EMR164.94-5.80 (-3.40%) ▼|FDX313.28+5.46 (+1.77%) ▲|GD372.61+1.79 (+0.48%) ▲|GE301.83-11.22 (-3.58%) ▼|GEV857.75-30.10 (-3.39%) ▼|GILD170.68+5.07 (+3.06%) ▲|GM87.40+1.68 (+1.96%) ▲|GOOG278.22-4.10 (-1.45%) ▼|GOOGL279.84-3.98 (-1.40%) ▼|GS894.45-33.28 (-3.59%) ▼|HD329.20+0.22 (+0.07%) ▲|HON218.33-3.81 (-1.72%) ▼|IBM257.81-0.47 (-0.18%) ▼|INTC65.76-26.31 (-28.58%) ▼|INTU341.09+9.90 (+2.99%) ▲|ISRG432.01-16.75 (-3.73%) ▼|JNJ273.20-2.00 (-0.73%) ▼|JPM337.04-6.54 (-1.90%) ▼|KO94.08+1.26 (+1.36%) ▲|LIN514.24+11.09 (+2.20%) ▲|LLY1,417.54+43.84 (+3.19%) ▲|LMT636.95-6.64 (-1.03%) ▼|LOW209.07+1.79 (+0.86%) ▲|LRCX239.11-15.28 (-6.01%) ▼|MA638.01+2.31 (+0.36%) ▲|MCD258.12+0.74 (+0.29%) ▲|MDLZ64.94+2.41 (+3.85%) ▲|MDT96.54-0.57 (-0.59%) ▼|META614.99-9.53 (-1.53%) ▼|MMM174.34-3.02 (-1.70%) ▼|MO78.03+1.28 (+1.67%) ▲|MRK149.52+3.19 (+2.18%) ▲|MS184.30-4.55 (-2.41%) ▼|MSFT521.91-8.23 (-1.55%) ▼|MU884.74-49.53 (-5.30%) ▼|NEE83.65+1.51 (+1.84%) ▲|NFLX61.82-0.23 (-0.37%) ▼|NKE38.59+0.17 (+0.43%) ▲|NOW104.94-4.73 (-4.31%) ▼|NVDA203.24-10.43 (-4.88%) ▼|ORCL130.67-8.89 (-6.37%) ▼|PEP137.34+3.55 (+2.65%) ▲|PFE30.52+0.57 (+1.90%) ▲|PG161.57+0.98 (+0.61%) ▲|PLTR184.11-12.31 (-6.27%) ▼|PM208.79+0.29 (+0.14%) ▲|QCOM164.68-20.73 (-11.18%) ▼|RTX199.80+0.40 (+0.20%) ▲|SBUX104.74-0.77 (-0.73%) ▼|SCHW87.70-1.77 (-1.98%) ▼|SO94.17+1.18 (+1.27%) ▲|SPG217.80+2.08 (+0.96%) ▲|T21.43+0.51 (+2.44%) ▲|TMO696.97-12.21 (-1.72%) ▼|TMUS156.44+9.15 (+6.21%) ▲|TSLA399.81-3.49 (-0.87%) ▼|TXN300.84-10.58 (-3.40%) ▼|UBER65.25-0.49 (-0.75%) ▼|UNH406.97-3.94 (-0.96%) ▼|UNP304.00+2.07 (+0.69%) ▲|UPS108.25+0.92 (+0.86%) ▲|USB59.45-1.19 (-1.96%) ▼|V413.59+3.05 (+0.74%) ▲|VZ44.73+1.07 (+2.45%) ▲|WFC83.40-1.41 (-1.66%) ▼|WMT123.51+2.26 (+1.86%) ▲|XOM187.25+3.96 (+2.16%) ▲|
20.9 C
New York
Friday, October 30, 2026

Tag: Complex

Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate

Study highlights potential to produce a value-added lithium chemical at site, offering further opportunities to reduce logistics intensity over time and aligning with Canada's...

Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate

Study highlights potential to produce a value-added lithium chemical at site, offering further opportunities to reduce logistics intensity over time and aligning with Canada's...

Bitcoin Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Join BTC and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.
Join BTC and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

Changan Group Unveils Its In-house Developed ADAS — SDA Pilot

CHONGQING, China, June 14, 2026 /PRNewswire/ -- At the 28th Chongqing International Auto Exhibition, Changan Group showcased its full brand lineup including CHANGAN NEVO,...

Lilly’s Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with...

BRUIN CLL-322 is the first Phase 3 study to demonstrate superiority over a venetoclax-containing control arm in CLL, and, with the majority of patients...

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...

Kos Biotechnology Partners Announces Third Closing of Global Life Sciences Fund at $123 Million

NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...

TTW Announces Top 50 Amusement Park Travel Destinations in the World for 2026

NEW YORK, June 13, 2026 /PRNewswire/ -- Travel And Tour World (TTW) today announced its Top 50 Amusement Park Travel Destinations in the World...

MGI Tech Showcases Expanding Genomics Ecosystem at ESHG 2026 with New IVD Partnering Program and OEM Collaborations

GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation...

Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement

Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.
Join XRP and top assets through AI-driven automated strategies with daily settlement—no manual trading needed.

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.1 The results showed that TALVEY® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).1 Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.1  

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus DARZALEX FASPRO® with or without pomalidomide showed progression-free survival of up to 81% and overall survival of up to 89% at 24 monthsMonumenTAL-3 is the...

EpiCooler Product Information Updated As Consumer Interest In Portable AC Grows In 2026

Kaunas, Lithuania, June 13, 2026 (GLOBE NEWSWIRE) --

An informational overview examining EpiCooler Portable AC Product Details, Publicly available product disclosures and what consumers often consider when researching portable cooling devices in 2026

HASA Inc. Acquires Swimming Pool Chemicals Manufacturer Bio-Dex Laboratories, Inc.

VALENCIA, Calif., June 12, 2026 /PRNewswire/ -- HASA Inc. (www.hasa.com), a leading producer and distributor of high-quality water treatment solutions, today announced the acquisition of Bio–Dex Laboratories,...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsComplex